Staying Healthy After Childbirth: My Hypertension Education and Reaching Target Program for Postpartum
STAC-MyHEARTp
2 other identifiers
interventional
140
1 country
1
Brief Summary
A study of Staying Healthy After Childbirth (STAC) and My Hypertension Education And Reaching Target (MyHEART) for postpartum (p) patients to determine if health coaching can increase 12-month postpartum care attendance, hypertension control and hypertension self-management behavior compared to usual clinical care in patients with chronic hypertension or persistent pregnancy associated hypertension - postpartum. 140 participants will be enrolled and can expect to be on study for 12 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable hypertension
Started Feb 2023
Typical duration for not_applicable hypertension
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 5, 2023
CompletedFirst Posted
Study publicly available on registry
January 17, 2023
CompletedStudy Start
First participant enrolled
February 22, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 10, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 10, 2025
CompletedAugust 28, 2025
April 1, 2025
2.1 years
January 5, 2023
August 20, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of Participants Who Attend 12 month Postpartum Care Visit
up to 12 months
Secondary Outcomes (12)
Difference in Self-Reported and Electronic Medical Record (EMR) documented BP at 6 months postpartum
up to 6 months
Lipid Profile at 12 months postpartum
12 months
Hemoglobin A1c at 12 months postpartum
12 months
Microalbumin Creatine Ratio at 12 months postpartum
12 months
Percentage of participants that achieve hypertension control at 12 months postpartum
12 months
- +7 more secondary outcomes
Study Arms (2)
Health Coaching
EXPERIMENTALStandard of Care
NO INTERVENTIONInterventions
Participants will receive a health coach telehealth/video visit or phone call every 2 weeks for 4 months, for a total of 8 calls. After these initial 8 calls, at approximately 6 months postpartum, the health coach will schedule maintenance calls 1 per month until approximately 12 months postpartum, for a total of 6 additional calls.
Participants will be provided an A\&D UA-651 (BT) home blood pressure monitor with an appropriate cuff size, they will be asked to take their blood pressure at least three days a week, 2 measurements each time
Eligibility Criteria
You may qualify if:
- Willing and capable of giving written informed consent
- Willing to comply with all study procedures and be available for the duration of the study
- Genetically female
- Patients who complete the 6-week program, had a hypertension disorder of pregnancy who have persistent hypertension (systolic blood pressure greater than 130 mmHg or diastolic blood pressure greater than 80 mmHg) and/or are still on antihypertensive medication and those with chronic hypertension (CHTN) will be eligible to participate.
- Medically homed at UW Health or UPH
You may not qualify if:
- Inability to participate in health coaching (i.e., no reliable phone contact or Wi-Fi
- History of medically determined Congestive Heart Failure
- Unable to provide informed consent (i.e., activated healthcare power of attorney)
- Unable or unwilling to travel to local clinic for research visits
- Currently residing in a skilled nursing facility
- Diagnosed with sickle cell anemia or cystic fibrosis
- Diagnosed with stroke, myocardial infarction, and/or coronary artery revascularization in the past 2 years
- Syncope while exercising or doing strenuous activity within past 12 months
- Currently prescribed warfarin, novel oral anticoagulant, or insulin
- Planned organ transplant or prior transplant in the past 5 years
- Chemotherapy or radiation therapy within 6 the past months
- Severely impaired hearing, vision, or speech, as determined by study staff responsible for enrollment
- Current participation or planning to participate in another clinical trial in the next 12 months that involves hypertension management/control
- Pregnant or planning to become pregnant in the next 12 months
- Planning to leave the geographic area in the next 12 months
- +8 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Wisconsin, Madisonlead
- Meriter Foundationcollaborator
Study Sites (1)
UW Hospital and Clinics
Madison, Wisconsin, 53792, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kara K Hoppe, DO
University of Wisconsin, Madison
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 5, 2023
First Posted
January 17, 2023
Study Start
February 22, 2023
Primary Completion
April 10, 2025
Study Completion
April 10, 2025
Last Updated
August 28, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will share